Literature DB >> 326043

Terminal half-lives of drugs studied in patients with hepatic diseases.

R G Closson.   

Abstract

Published evidence of the effects of liver diseases on the terminal half-lives of drugs in man is presented. Formulas are given to aid the reader in determining the hepatic clearance of drugs. The effect of various liver diseases on hepatic function is reviewed. Data on 38 drugs are tabulated.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 326043

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  2 in total

1.  Pharmacokinetics of oral brotizolam in patients with liver cirrhosis.

Authors:  R Jochemsen; R P Joeres; J G Wesselman; E Richter; D D Breimer
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

Review 2.  Trimethoprim: a review of its antibacterial activity, pharmacokinetics and therapeutic use in urinary tract infections.

Authors:  R N Brogden; A A Carmine; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-06       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.